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Genetic polymorphismbecomes one of the most important mosquito-borne alphavirus in the medical
ﬁeld. CHIKV is highly sensitive to antiviral activity of Type-I interferons (IFN-α/β). Here, we investigated the
role of IFN-induced 2′,5′-Oligoadenylate Synthetase (OAS) family in innate immunity to CHIKV. We
established inducible human epithelial HeLa cell lines expressing either the large form of human OAS, OAS3,
or the genetic variant OAS3-R844X which is predicted to lack about 20% of the OAS3 protein from the carboxy
terminus. HeLa cells respond to ectopic OAS3 expression by efﬁciently inhibiting CHIKV growth. The
characteristic of the antiviral effect was a blockade in early stages of virus replication. Thus, OAS3 pathway
may represent a novel antialphaviral mechanism by which IFN-α/β controls CHIKV growth. HeLa cells
expressing the truncated form of OAS3 were less resistant to CHIKV infection, raising the question on the
involvement of OAS3 genetic polymorphism in human susceptibility to alphavirus infection.
© 2008 Elsevier Inc. All rights reserved.Introduction
Chikungunya fever is an arbovirosis of major impact in public
health in Asia and Africa. Chikungunya virus (CHIKV) has been
responsible for an unprecedented magnitude of outbreaks in the
Indian Ocean (Schuffenecker et al., 2006) and in Indiawhere hundreds
of thousands of people have been infected since 2005 (Epstein, 2007).
Humans infected with CHIKV typically experience acute illness with
incapacitating polyarthralgia, severe muscle pain, and stiffness in the
joints. CHIKV infection in muscle tissue could explain some features of
clinical manifestations (Ozden et al., 2007; Couderc et al., 2008).
CHIKV, Sindbis virus (SINV), and Semliki Forest virus (SFV) are
members of the Alphavirus genus of the Togaviridae family. Alpha-
viruses are lipid enveloped, positive-sense, single-stranded (ss) RNA
viruses that replicate in the cytoplasm of the infected cells (for reviewcontacted at Génétique de la
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l rights reserved.Strauss and Strauss, 1994; Grifﬁn, 2007). The alphavirion contains an
11.5 kb, single-stranded RNA genome of positive polarity. The genomic
RNA is directly translated into the non-structural proteins 1 to 4 (nsP-1
to -4), which are encoded by the 5′ two-thirds of the genome. The
structural proteins are encodedwithin the 3′ one-third of the genomic
RNA and are translated from the subgenomic 26S RNA. The three
major structural proteins C (capsid), E2 and E1 (the both envelope
glycoproteins) together with genomic RNA form the alphavirion.
Alphavirus infection results in rapid inhibition of cellular machinery,
which favours the production of viral RNA and proteins inside the host
cells (for review Strauss and Strauss, 1994).
Alphaviruses such as CHIKV are highly sensitive to the antiviral
activity of Type-I interferons (IFN-α/β) (Desprès et al., 1995; Ryman
et al., 2005; Lenschow et al., 2007; Shabman et al., 2007; Sourisseau
et al., 2007; Zhang et al., 2007; Couderc et al., 2008; Tesfay et al.,
2008).
Innate antiviral mechanisms mediated by IFN-α/β are potentially
the most important pathways of host cell defence limiting viral
replication (for review, Samuel, 2001). Recent reports have shown that
IFN-α/β is able to trigger the activation of a speciﬁc signal
transduction pathway leading to induction of IFN-stimulated genes
(ISGs) that are responsible for the establishment of an antialphaviral
state (Lenschow et al., 2007; Zhang et al., 2007). To date, the ISGs
thought to affect alphavirus replication are ISG15, ISG20, P56, ZAP, and
Table 1
Amino acid differences between available OAS3 sequence (GenBank access NM-006178)
and OAS3 cDNAs used in this study
AA position NM-006178 OAS3 OAS3-R844X
18 Arg Lys Lys
844 Arg Arg Opal
865 Trp Ser –
217A.-C. Bréhin et al. / Virology 384 (2009) 216–222Viperin (Lenschow et al., 2007; MacDonald et al., 2007; Zhang et al.,
2007).
It is currently unknown whether any members of IFN-induced
2′,5′-Oligoadenylate Synthetase (OAS) family may play a role in the
establishment of an antialphaviral state. The OAS/RNase L is a RNA
decay pathway known to play an important role in the established
endogenous antiviral pathway (Justesen et al., 2000; Sarkar et al.,
1999; for review, Samuel, 2001; Ryman et al., 2005; Silverman,
2007; Randall and Goodbourn, 2008). Human OAS is a family of
enzymes encoded by three closely linked genes on chromosome
12q24.2, with the following order: small (OAS1, p40/p46), medium
(OAS2, p69/71), and large (OAS3, p100) OAS isoforms. The OAS
proteins contain one (p40/p46), two (p69/71), or three (p100)
repeats of the basic OAS module. Very little information is available
on the biological properties of OAS3 (for review, Rebouillat and
Hovanessian, 1999). The IFN-dependent OAS proteins are a group of
double-strand (ds) RNA-dependent enzymes (for review Rebouillat
and Hovanessian, 1999; Rebouillat et al., 2000). Binding of
enzymatically active OAS to activator viral RNA results in the
production of 2′- to 5′-linked oligoadenylates (2-5A). Latent,
monomeric RNase L is enzymatically activated through homo-
dimerization induced by binding to 2-5A oligomers. Once activated,
RNase L degrades single-stranded RNA molecules including mRNA
and viral RNA (for reviews, Samuel, 2001; Silverman, 2007).
We and others demonstrated that 1b isoform of mouse OAS gene
(Oas1b) is a critical component of innate immunity to West Nile virus
in vivo and in vitro (Mashimo et al., 2002; Perelygin et al., 2002;
Kajaste-Rudnitski et al., 2006). We also reported that Oas1b is capable
of suppressing ﬂavivirus infection in RNase L-deﬁcient mouse cells
(Kajaste-Rudnitski et al., 2006). In the case of alphaviruses, a body of
evidence exists to suggest that IFN-mediated inhibition of virus
growth does not require RNase L (Ryman et al., 2005; for review,
Silverman, 2007). Because the large form of human OAS is presumably
not involved in RNase L activation (for review, Rebouillat and
Hovanessian, 1999), we investigated whether OAS3 exerts an antiviral
effect on CHIKV infection in human epithelial cells.Fig. 1. Susceptibility of HeLa cells to CHIKV. In (A), HeLa.Tet-Off cells were infectedwith CHIKV
AP61 cells. In (B), HeLa.Tet-Off cells were treated with 1000 IU.mL–1 human IFN-α or mock-tr
determined at 18 h p.i as described above. In (C), antiviral action of IFN-α on CHIKV growth. He
human IFN-α at various time points p.i. Percentage of CHIKV progeny production in IFN-treaResults and discussion
Susceptibility of HeLa.Tet-Off cells to CHIKV
Our preliminary data showed that a high level of OAS3 expression
after transfectionwith non-inducible DNA expression vectors resulted
in great instability of OAS3 in transfected human cell lines (data not
shown). To assess the antiviral activity of the large form of humanOAS,
we decided to establish a tetracycline-inducible human epithelial cell
line with a stably integrated human OAS3 cDNA (Table 1) that allows
induction of OAS3 expression by the removal of tetracycline (Tet)
repressor.
To our knowledge, no stable cell lines expressing the large form of
human OAS have been reported to date. Our previous attempts to
generate a stable human cell line which allows inducible expression of
OAS3 showed that HeLa.Tet-Off cell line was available for production
of OAS3. To validate the susceptibility of HeLa.Tet-Off cells to CHIKV
infection, these cells were exposed to an increasing input of La
Réunion CHIKV strain 06-49 (Schuffenecker et al., 2006; Bréhin et al.,
2008) (Fig. 1A). An analysis of CHIKV replication in HeLa.Tet-Off cells
infected at 1 multiplicity of infection (MOI) showed that production of
progeny virus reached ~7 log FFU.mL–1 at 18 h p.i. At this time point of
infection, CHIKV infection resulted in detection of ∼50% cells that
were positive in ﬂow cytometry analysis with anti-CHIK.E2 MAb 3E4
(Bréhin et al., 2008) (data not shown). Thus, HeLa.Tet-Off cells show
susceptibility to CHIKV growth.
Recent attention has focused on the role of IFN-α/β in the antiviral
innate immune responses against CHIKV in human cells (Sourisseau
et al., 2007; Couderc et al., 2008). Thus, we examine the ability of
human IFN-α to establish an antiviral state in HeLa.Tet-Off cells.
Treatment of HeLa.Tet-Off cells with 1000 IU.mL–1 human IFN-α 5 h
prior CHIKV exposure (1 MOI) resulted in ∼1.5 log reduction in virus
progeny production at 18 h p.i. (Fig. 1B). Thus, IFN-dependent antiviral
pathways are functional in HeLa.Tet-Off cells and provide protection
against CHIKV at cellular level. However, CHIKV-infected HeLa.Tet-Off
cells showed complete resistance to IFN-α at 5 h p.i. once virus
replication is well established (Fig. 1C).
Establishment of OAS3-expressing HeLa cell lines
To investigate the antiviral effect of OAS3 against CHIKV, we
established a HeLa.Tet-Off/OAS3 cell clone that up-regulates OAS3
protein expression under the control of the Tet-Off expression system.
The recombinant OAS3 protein is composed of three adjacent OAS
units (domains I, II, and III) including three potential active catalyticat differentMOI. At 20 h p.i., virus particles produced in the supernatantswere titered on
eated (control) 5 h prior to CHIKV 06-49 input at 1 MOI. Virus progeny productions were
La.Tet-Off cells were infectedwith CHIKV at 1MOI. Cells were treatedwith 1000 IU.mL−1
ted cells relative to that in mock-treated cells (% to control) at 20 h p.i.
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number of HeLa.Tet-Off/OAS3 cell clones were capable of OAS3
production and the most efﬁcient designated HeLa.Tet-Off/
OAS3#3C4 was used in all further studies. Expression of recombinant
OAS3 in these cells was assessed by immunoblotting assay with a
polyclonal immune serum directed against the C-terminal region of
human OAS3 protein (Fig. 2B). As a positive control, the production of
endogenous OAS3molecules was clearly detected in IFN-treated HeLa.
Tet-Off cells (Fig. 1D, control, + IFN). whereas no basal expression of
OAS3 was observed in resting cells (Fig. 1D, control, mock).
Immunoblot analysis detected a basal level of OAS3 molecules in
uninduced HeLa.Tet-Off/OAS3 cells indicating that shut-off was
incomplete (Fig. 1D, OAS3, +tet). When the repressor Tet was removed
24 h from the culture medium, there was an increase in production
level of recombinant OAS3 protein (Fig. 1D, OAS3, −tet).
By sequencing the 16 exons, ﬂanking introns and 2 kb region 5′ to
the OAS3 gene in forty-eight healthy Caucasians individuals, we
identiﬁed a single-nucleotide polymorphism (SNP) at the ﬁrst position
of codon CGA-844 where the substitution T for C resulted in a non-
sense mutation (OAS3.R844X) (Table 1). We further genotyped this
SNP in 180 healthy Caucasian individuals and identiﬁed two
heterozygous individuals, resulting in an overall estimate of allele
frequency of 0.5%. OAS3.R844X is expected to result in a trun-
cated form of OAS3 protein, lacking about 20% from the carboxy-
terminus (Fig. 1C). Consequently, we constructed a stable HeLa.Tet-off/
OAS3ΔC-term.# 1C cell clone expressing the OAS-1 to OAS3–843
sequence. The OAS3ΔC-term. lacks the D889 residue which composes
the triad deﬁning the active catalytic site of the third domain of OAS3
(Sarkar et al., 1999; Rebouillat et al., 2000). Immunoblot analysis using
immune serum directed against the N-terminal region of human OAS3
protein detected the truncated form of OAS3 protein only in induced
HeLa.Tet-off/OAS3ΔC-term. cells (Fig. 2C).
Antiviral effects of OAS3 against CHIKV
To determine the extent bywhich CHIKVwas capable of replicating
in OAS3-expressing HeLa cells, HeLa.Tet-Off/OAS3 cells were exposed
to CHIKV at 1MOI (Fig. 2A). Flow cytometry analysis of CHIKV-infected
HeLa.Tet-Off cells with Cy3-conjugated MAb 3E4 detected nearly 40%
of E2-positive cells (Fig. 3A, control) at 18 h p.i. whereas pre-treatment
of these cells with IFN-α resulted in ∼5% cells that were positive forFig. 2. Detection of OAS3 in inducible HeLa.Tet-Off/OAS3 cell lines. In (A), the graph depic
(B), immunoblot analysis of OAS3 expression in HeLa.Tet-Off cells incubated with IFN-α (c
induced (OAS3, −Tet) HeLa.Tet-Off/OAS3 cells using anti-OAS3 C-term. antibodies. To ensure a
the culture medium. The β-actin served as a house-keeping protein control. In (C), detecti
(control) and uninduced (+Tet) or induced (−Tet) HeLa.Tet-Off/OAS3ΔC-term. cell lysates were
house-keeping protein control.viral antigen (Fig. 3A, + IFN-α). In contrast with that found in parental
cells, only 9 to 11% of HeLa.Tet-Off/OAS3 cells were detected positive
for CHIKV infection. There was a comparable degree of inhibition in
CHIKV replication between uninduced (Fig. 3A, +tet) and induced
HeLa.Tet-Off/OAS3 cells (Fig. 3A, −Tet). Thus, human epithelial cells
respond to OAS3 expression by efﬁciently inhibiting CHIKV infection.
To further assess the efﬁciency with which OAS3 inhibits CHIKV
growth, virus progeny production in HeLa.Tet-Off/OAS3 cells was
compared with that in parental HeLa.Tet-Off cells (Fig. 3B). Studies
were performed without Tet to avoid any inhibitory effect of antibiotic
on infectivity of released CHIKV. The culture ﬂuids were harvested at
18 h p.i. and examined by infectivity assay on mosquito AP61 cells. We
found that expression of recombinant OAS3 protein reduced the
progeny virus production by 1.5 to 2.0 log regardless of the MOI tested.
At 24 h p.i., there was ∼3.0 log reduction in the viral titer at the lower
MOI tested. However, viral growth was reduced only by ∼0.5 log when
CHIKV infection was performed at high virus input (10 MOI). This
relative inefﬁciency of OAS3 could be attributed to viral components
which are produced at sufﬁcient levels to attenuate its antiviral activity.
Measurements of LDH activity released from CHIKV-infected HeLa.
Tet-Off/OAS3 cells showed no signiﬁcant loss of cell viability within
the ﬁrst 24 h of infection as compared to infected parental cells (data
not shown). Thus, the resistance to CHIKV infection was directly
related to the antiviral activity of the OAS3 rather than elimination of
virus-infected HeLa cells through cytopathic effects.
Kinetic studies showed that OAS3-mediated inhibition of CHIKV
was effective during virus life cycle (Fig. 3C). At 12 h p.i., there was a
2.0 log reduction in the viral titer recovered from HeLa.Tet-Off/OAS3
cells as compared with HeLa.Tet-Off cells. Induction of OAS3 protein
expression was still able to reduce the progeny virus production by at
least 1.5 log at 24 h p.i. Given that OAS3-mediated inhibition of CHIKV
was essentially preserved within the 24 h p.i., it is likely that CHIKV
was unable to counteract the antiviral action of OAS3 to its own
advantage.
We assessed the ability of mutant OAS3.R844X to inhibit CHIKV
growth. Induced HeLa.Tet-Off/OAS3 and HeLa.Tet-off/OAS3ΔC-term.
cells were infected with CHIKV 06-49 at 1 MOI. Analysis of viral
growths showed that ectopic expression of OAS3ΔC-term. resulted in a
lower efﬁciency of CHIKV inhibition as compared to full-length OAS3
protein (Fig. 3D). This result suggests that SNP at codon CGA-844 may
have an impact on the antiviral activity of OAS3. The ﬁnding thatts the structures of full-length OAS3 protein and the truncated form OAS3ΔC-term.. In
ontrol, +IFN) for 24 h or mock-treated (control, mock) and uninduced (OAS3, +Tet) or
n optimal production of recombinant OAS3 protein, tetracyclinewas removed 24 h from
on of the truncated form of OAS3 in HeLa.Tet-Off/OAS3ΔC-term. cells. HeLa.Tet-Off cells
analyzed by immunoblotting with anti-OAS3 N-term antibodies. The β-actin served as a
Fig. 3. Inhibition of CHIKV growth in OAS3-expressing HeLa cells. In (A), cells were infected 18 h with CHIKV 06-49 at 1 MOI and analyzed by ﬂow cytometry with Cy3-
conjugated MAb 3E4 directed against CHIKV E2 glycoprotein. Percentage of infected HeLa.Tet-Off cells incubated with 1000 IU.mL–1 IFN-α (+IFN-α) 24 h prior virus input or
mock-treated (control), and infected HeLa.Tet-Off/OAS3 cells in the presence (+tet) or in absence (−tet) of Tet. The background of mock-infected cells was b0.5%. In (B), HeLa.Tet-
Off (close box) and induced HeLa.Tet-Off/OAS3 (grey box) cells were infected with CHIKV at different MOI and virus progeny productions were determined at 18 and 24 h p.i. In
(C), induced HeLa.Tet-Off/OAS3 cells were infected with CHIKV at 1 MOI and viral growth was monitored at various times p.i. In (D), induced HeLa.Tet-Off/OAS3 (OAS3) and
HeLa.Tet-Off/OAS3ΔC-term. (OAS3ΔC-term.) cells were infected with CHIKV at 1 MOI and virus progeny productions were determined at 18 h p.i. The values were compared
statistically according to Student's t tests (⁎⁎⁎: Pb0.001).
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indicates that OAS-1 to OAS3-843 sequence is still able to provide
signiﬁcant protection.
Antiviral action of OAS3 against alphaviruses
We examined whether the large form of human OAS is able to inhibit
growth of other alphaviruses such as SINV and SFV in human epithelial
cells (Fig. 4A). HeLa.Tet-Off and induced HeLa.Tet-Off/OAS3 cells were
infected with alphaviruses at 1 MOI. In response to OAS3 protein
expression, there was a comparable degree of inhibition (∼2 log) in
progenyvirusproductionbetweenSINVandSFVat 18hp.i. Thus, different
alphaviruses can be greatly suppressed by the antiviral activity of OAS3.
We examined whether OAS3 displays antiviral activity against
other RNAviruses of medical interest such as ﬂavivirus (positive-sense
ssRNA) and morbillivirus (negative-sense ssRNA). Because human
epithelial cells are permissive to Schwarz (Schw.) vaccine strain of
measles virus (MV) and live-attenuated 17D vaccine strain of yellow
fever virus (YFV), parental Hela.Tet-Off and HeLa.Tet-Off/OAS3 cells
were exposed to MVSchw. or YFV 17D. There were no obvious
differences in MVSchw. replication between both cell populations
(data not shown). Also, there was no signiﬁcant inhibition of YFV 17Dgrowth in OAS3-expressing HeLa cells (Fig. 4A). Since IFN-α was able
to establish an antiviral state against YFV strain 17D in infected HeLa.
Tet-Off cells (Fig. 4B), we can rule out the possibility that over-
expression of OAS3 resulted in Type-I IFN induction that might
account for any antiviral effects observed in human epithelial cells.
Taken together, these results show that alphaviruses are particularly
sensitive to OAS3 expression in human cells.
Mechanisms of OAS3-mediated CHIKV inhibition
In an effort to resolve the molecular basis of the antiviral action of
OAS3, we ﬁrst determined whether inhibition of CHIKV growth was
due to a lack of accumulation of structural virus proteins. Total
proteins were extracted from Hela.Tet-Off and HeLa.Tet-Off/OAS3 cells
at the 18 h p.i. and C, pE2 (precursor of E2), E2, and E1 were detected
by immunoblot usingmouse anti-CHIKV polyclonal antibodies or anti-
CHIKV E2 MAb 3E4 (Fig. 5A). There was a background level of
structural virus proteins in response to OAS3 protein expression. Thus,
the inability of CHIKV to productively infect OAS3-expressing HeLa
cells is associated with a severe reduction in viral protein synthesis.
We determined whether the inefﬁciency of viral protein synthesis
was due to a lack of accumulation of viral RNA. Total RNAwas extracted
Fig. 4. Antialphaviral activity of OAS3. In (A), HeLa.Tet-Off (close box) and induced HeLa.Tet-Off/OAS3 (grey box) cells were infected at 1 (SINV and SFV) or 10 (YFV) MOI and virus
progeny productions were determined at 18 h (SINV and SFV) or 72 h (YFV) p.i. In (B), HeLa.Tet-Off cells were infected with YFV 17D at 1 MOI and treated with 1000 IU.mL–1 human
IFN-α at various time points p.i. or mock-treated (control). Virus progeny productions were determined at 72 h p.i.
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infection and production of genomic and subgenomic viral RNAs was
analyzed using RT-PCR assay with primers designed on the basis of
CHIKV E2 gene. As determined by real-time RT-PCR analysis, therewas a
2 log reduction in viral RNA level recovered from OAS3-expressing cells
when compared to that found in parental cells (Fig. 5B). Thus, OAS3
expression prevents viral RNA accumulation inside infected cells. To
address the role of RNase L in the antiviral action of OAS3, we inhibited
endogenous RNase L using a small interfering RNA duplex (siRNA)
approach. Speciﬁc targeting siRNA 1890 (Table 2) was able to reduceFig. 5. Consequences of OAS3 expression for CHIKV replication. In (A), immunoblot assay was
CHIKV (virus) or mock-infected (m.i.) using anti-CHIK HMAF (left) or anti-CHIKV E2 MAb 3E
RNA production in HeLa.Tet-Off cells (control) and induced HeLa.Tet-Off/OAS3 cells (OAS3)
copies was performed as described in the Materials and Methods. In (C), a consequence of
RNase L inhibition in HeLa.Tet-Off/OAS3 cells transfected 20 h with nontargeting negativ
transfected (no siRNA). The design and the production of siRNA 1890 were made by GeneCu
transfected were infected with CHIKV at 1 MOI. Real-time RT-PCR analysis of viral RNA produ
average.RNase L expression level after transfection of HeLa.Tet-Off/OAS3 cells
(Fig. 5C). Since siRNA-mediated inhibition of RNase L was ineffective to
promote CHIKV growth in OAS3-expressing HeLa cells (Fig. 5C), it seems
unlikely that OAS3 affects CHIKV replication through a RNase L-
dependent pathway.
Concluding remarks
Our data suggest a role for the large form of human OAS in the
established endogenous antiviral pathway against CHIKV infection.performed on cell extracts from HeLa.Tet-Off and HeLa.Tet-Off/OAS3 cells infected with
4 (right). The β-actin served as protein control. In (B), real-time RT-PCR analysis of viral
infected with CHIKV at 1 MOI was performed at 8 h p.i. The quantiﬁcation of viral RNA
down-regulation of RNase L on OAS3 inhibition of CHIKV. Left, immunoblot analysis of
e control siRNA (siRNA NC), speciﬁc targeting siRNA 1890 (siRNA RNase L) or mock-
st Co. (Luxembourg). Right, induced HeLa.Tet-Off/OAS3 cells transfected 20 h or mock-
ctionwas assessed at 8 h p.i. as described above. Error bars indicate deviations from the
Table 2
Sequences of primers used in this study
Primer Nucleotide sequence (5′→3′)
OAS3.R844X-F GTGGTGTTCCTCAGCTGCTT
OAS3.R844X-R CATCGTCTGGGATGTCAGTG
pTet-OAS3-univ1 ATTAATGCGGCCGCAACGAAACCAGAAATCCGAAGGCC
pTet-OAS3-rev2 AACTAACTATAGTCAAAGGTCCTCCTTGGAGATGAGCTTCTGTTCCACAGCAGCCTTCACTGGCCATGGCTGGATGGG
pTet-OAS3-univ-1bis ATTAATGCGGCCGCATGGACTTGTACAGCACCCCGGCCGCTGCG
pTet-OAS3-rev-3bis AACTAACTATAGTCAAAGGTCCTCCTTGGAGATGAGCTTCTGTTCGATCTCGGAGATGATCTCGGCCCGCCGCTTGTTGCC
OAS3ecto-For CGGACGGTGCTGGGGCTCGTG
OAS3ecto-Rev CTTGTCTTCGAGTAGAGGCTTCTC
Chik/E2/9018/+ CACCGCCGCAACTACCG
Chik/E2/9235/− GATTGGTGACCGCGGCA
GAPDH-For GGGAGCCAAAAGGG
GAPDH-Rev GGGGACACGGAAGG
hRNaseL-For GCGTGAAGCTGCTGAAACTT
hRNaseL-Rev ACTTGGGTTTGGTGCAGAGG
siRNA 1660 GCUCAGUUCUGGCACCAAATT
UUUGGUGCCAGAACUGAGCTG
siRNA 1890 AGUGGACGACUAAGAUUAATT
UUAAUCUUAGUCGUCCACUTG
Enzyme recognition site are underlined. Sequence complementary to a stop codon are shown in bold.
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inside infected cells. However, we cannot rule out the possibility that
OAS3-mediated inhibition of CHIKV was also due to a block early in
virus life cycle, e.g., viral entry and uncoating of virus particles.
We consider that the ability of OAS3 to inhibit alphavirus growth
may be important for the development of antiviral molecules against
CHIKV. One of the critical issues to be addressed in the future relates to
a precise biochemical mechanism of OAS3-dependent antialphaviral
activity. Experiments will be undertaken to determine whether
antiviral effect of OAS3 may be mediated by binding to viral RNA
duplexes such as particular secondary structures within the genomic
or antigenomic RNA as well as replicative forms produced during
alphavirus replication (for review, Grifﬁn, 2007).
There was a background level of intracellular viral RNA in response
to OAS3 protein expression. Using a siRNA approach, we showed that
reduction in RNase L expression did not rescue the inability of CHIKV
to productively infect human cells expressing OAS3. This might reﬂect
a possibility that OAS3mediates resistance to alphavirus infection by a
RNase L-independent mechanism. We showed that expression of
OAS3 was effective in blocking viral protein synthesis inside infected
human cells. Recently, it was reported that IFN-α/β could control
alphavirus replication in inhibiting cap-dependent translation of viral
RNA (Zhang et al., 2007; Tesfay et al., 2008). On the basis of this
observation, it is tempting to speculate that OAS3 possesses inhibitory
translation activity that might compromise viral protein production.
Whether OAS3 potently inhibits alphaviral mRNA translation is a
critical issue that will be the subject of further investigation.
A siRNA approach was developed to determine whether reduction
in OAS3 expression was effective to promote CHIKV replication in
HeLa cells exposed to IFN. Although speciﬁc targeting siRNA 1660
(Table 2) was able to reduce OAS3 mRNA expression after transfection
of IFN-treated cells, no rescue of CHIKV growth was observed in these
cells (data not shown). This might reﬂect the possibility that
redundant antiviral activities of the different ISGs prevent the
detection of individual effects of OAS3 against CHIKV.
Very little information is available on the human genetic suscep-
tibility to alphavirus infection. Screening the OAS3 gene for polymorph-
ism identiﬁed the genetic variant OAS3.R844X in Caucasian individuals.
In vitro, CHIKVwas less sensitive to the antiviral activity of OAS3 protein
lacking the C-terminal Domain III. The notion that genetic polymorph-
ism of OAS3 could control its antialphaviral activity opens a new avenue
for elucidating the role of human OAS genes in the pathogenesis of
alphavirus-related diseases such as Chikungunya fever.Materials and methods
Cell cultures
The HeLa.Tet-Off cell line was purchased from BD Biosciences
Clontech. HeLa.Tet-Off cells are maintained in DMEM (Invitrogen),
supplemented with 10% heat-inactivated foetal calf serum (FCS),
4mM glutamine and 200 μgmL−1 G418 (Invitrogen). The HeLa.Tet-Off/
OAS3 cell line is maintained in DMEM/10% FCS/4 mM glutamine
supplemented with 200 μg mL−1 G418, 100 μg mL−1 Hygromycin (BD
Biosciences Clontech), and 2 μg mL− 1 Tetracyclin (Sigma-Aldrich).
Viruses
Production of clinical isolate CHIKV strain 06-49 on mosquito
Aedes pseudoscutellaris (AP61) cell monolayers and virus titrationwere
performed as previously described (Bréhin et al., 2008). Infectivity
titers were expressed as focus forming units (FFU) on AP61 cells. SINV
strain AR339, SFV strain SF64, and YFV strain 17D (STAMARIL, Aventis-
Pasteur) were propagated on African green monkey kidney (VERO)
cell line and infectivity titers were expressed as plaque forming units
(PFU) on VERO cells. In order to assay its antiviral effect, human IFN-α
(BioSource) was directly added to culture medium.
Genotyping
The SNP OAS3.R844X was genotyped by PCR-RFLP assay using the
couple of primersOAS3.R844X-FandOAS3.R844X-R (Table 2). The183bp-
long PCR product was subjected to digestionwith Bgl II and the detection
of two fragments of 115 and 68 bp indicated the presence of OAS3.R844X.
Establishing HeLa.Tet-Off cell lines expressing OAS3 proteins
The plasmids PCR4-TOPO (Invitrogen) containing the cDNA coding
for two overlapping regions of the large form of human OASwere used
as templates for expression of the full-length OAS3 protein (aa 1 to
1087) or the truncated form OAS3ΔC-term. (aa 1 to 843) (Table 1). The
OAS3 sequences were modiﬁed by PCR to be ﬂanked on the 3′ open
reading frame end by an additional sequence (EQKLISKEDL) fol-
lowed by a stop-codon with the couple of primers pTet-OAS3-
univ1 and pTet-OAS3-rev2 for OAS3 and the couple of primers pTet-
OAS3-univ1bis and pTet-OAS3-rev2bis for OAS3[1–843] (Table 2). The
OAS3 sequences are ﬂanked by the NotI and EcoRV restriction
222 A.-C. Bréhin et al. / Virology 384 (2009) 216–222enzymatic sites at the downstream and upstream ends, respectively.
The PCR products were digested with NotI and EcoRV and then
inserted into the unique sites NotI and EcoRV of pTRE2hyg expression
vector (BD Biosciences Clontech) to generate pTRE2/OAS3 and pTRE2/
OAS3[1–843]. HeLa.Tet-Off cells were transfected with pTRE2/OAS3 or
pTRE2/OAS3[1–843], selected on growth medium containing inhibitors
and then cloned from single cells by limiting dilution in the presence
of 10 μg mL−1 repressor Tetracycline (Tet). For Tet withdrawal, cell
monolayers were trypsined and cells were washed at least ﬁve times
with non-supplemented DMEM before replacing with DMEM/10% FBS
supplemented only with genotoxic drugs. The level of recombinant
OAS3 mRNA production in induced cells (−Tet) relative to that in
uninduced cells (+Tet) was determined by RT-PCR analysis using the
couple of primers OAS3-For and OAS3-Rev (Table 2). Based on these
experiments, the inducible HeLa.Tet-Off/OAS3#3C4 and HeLa.Tet-Off/
OAS3ΔC-term.#1C cell clones were selected. BothHeLa.Tet-Off/OAS3 cell
lines were maintained under repressing condition in the presence of
2 μg mL−1 Tet.
Real-time RT-PCR
Analysis of viral RNA accumulation was performed with an ABI
Prism 7700 sequence detection using the SYBR® Green PCR essentially
as described previously (Kajaste-Rudnitski et al., 2006). The primers
for endogenous OAS3 mRNA are OAS3endo-For and OAS3endo-Rev
(Table 2). The primers for CHIKV E2 gene are Chik/E2/9018/+ and Chik/
E2/9235/− (Table 2). GAPDH mRNA was used as an endogenous
sequence control for the normalization of each sample. The primers
GAPDH-For and GAPDH-Rev are listed in Table 2. For the quantiﬁcation
of viral RNA copies, an in vitro CHIK RNA transcript encoding the
N-terminal region of E2 was performed to build the standard curve as
previously described (Vazeille et al., 2007).
Immunoblot assays
Cellular proteins were subjected to immunoblot analysis as
previously described (Bréhin et al., 2008). Viral protein expression
was detected using anti-CHIKV hyperimmune mouse ascitic ﬂuids
(HMAF) or anti-CHIK.E2 MAb 3E4 (Bréhin et al., 2008). OAS3 protein
expression was detected using anti-OAS3 N-term (Santa-Cruz
Biotechnology) or OAS3 C-term (Abgent) antibodies. RNase L protein
expression was detected using a mouse monoclonal anti-RNase L
antibody (clone 2E9, Zymed Laboratories). β-actin expression was
detected using a mouse monoclonal β-actin antibody (Sigma-
Aldrich).
Flow cytometry analysis
Cells were detached and then ﬁxed with 3.2% paraformaldehyde in
PBS. Fixed cells were permeabilized, stained with Cy3-conjugated
MAb 3E4 and analyzed by ﬂow cytometry as described previously
(Bréhin et al., 2008).
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